RED HOT Contributors

 

STAT Plus: If not the US, who will pay for drug development?

0
CREDIT: This post was originally published on this site

A

merican taxpayers pour money into basic biomedical research, supporting the development of drugs that pharmaceutical companies sell back to those same taxpayers at exorbitant price tags — and in other countries for much less.

So the argument goes, striking some as unfair to Americans. But if the United States doesn’t underwrite the research, nobody else will, said Bruce Stillman, president of Cold Spring Harbor Laboratory, during a visit to STAT’s offices Thursday.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

About

We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast